Completed PHASE4 INTERVENTIONAL 2-arm NCT02570022

Liposomal Bupivacaine in Total Shoulder Arthroplasty (EXP-TSA)

Liposomal Bupivacaine Versus Interscalene Nerve Block for Pain Control After Shoulder Arthroplasty: A Prospective Randomized Trial

Sponsor: Henry Ford Health System

Conditions Pain

Interventions Inter-scalene nerve block Liposomal bupivacaine Ropivacaine

Updated 9 times since 2017 Last updated: Aug 17, 2016 Started: Oct 31, 2014 Primary completion: May 31, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain and is currently completed. Henry Ford Health System leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Henry Ford Health System

Data source: Henry Ford Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Detroit, United States